From Retico® to Forminol® Gummies: AronPharma Recognized Among Vitafoods Europe Innovation Awards Finalists.

From eye health innovation with Retico® to metabolic health support with Forminol® Gummies. Two consecutive Vitafoods Europe Innovation Awards finalist recognitions highlight AronPharma’s consistent focus on science-backed, consumer-ready nutraceuticals.

Innovation in nutraceuticals is no longer defined only by new ingredients. Today, true innovation means combining scientific credibility, consumer-friendly formats, quality, taste and market readiness in one finished product.

At AronPharma, this approach has been recognized internationally in two consecutive editions of the Vitafoods Europe Innovation Awards. In 2025, Retico® was named a finalist in the category for consumer-ready nutraceutical finished products. In 2026, AronPharma returned to the finalists list with Forminol® Gummies, once again confirming the company’s focus on science-based, ready-to-market food supplements.

For AronPharma, these distinctions are not isolated achievements. They reflect a long-term strategy: to develop nutraceutical products that connect in-house R&D, advanced formulation work and real consumer needs.

Retico® was developed as an innovative food supplement supporting eye health in the context of modern lifestyles, where screen exposure, visual fatigue and oxidative stress are becoming increasingly relevant topics for consumers. The formula is based on a carefully selected combination of active ingredients, including berry fruit extracts rich in anthocyanins, designed to support the growing eye health category with a science-driven and consumer-ready solution.

The recognition of Retico® at Vitafoods Europe Innovation Awards 2025 was an important milestone for AronPharma. It showed that eye health remains a dynamic and relevant category in the nutraceutical market, especially when supported by strong formulation expertise and a clear product concept.

One year later, AronPharma received another important recognition - this time for Forminol® Gummies, named a finalist at the Vitafoods Europe Innovation Awards 2026.

Forminol® Gummies represent a different, but equally important, area of nutraceutical innovation: metabolic health. The product combines a convenient, pectin-based gummy format with AP029, AronPharma’s unique, patent-pending blend of berry extracts from aronia, elderberry and blackcurrant. The formula was developed to support healthy glucose metabolism and respond to the increasing demand for accessible, easy-to-use food supplements in this category.

The gummy format is particularly important. Consumers increasingly expect supplements that are not only well-formulated, but also pleasant to use and easy to include in daily routines. Forminol® Gummies answer this need by combining a science-driven concept with a consumer-friendly form suitable for modern supplementation habits.

Both recognitions — Retico® in 2025 and Forminol® Gummies in 2026 — underline AronPharma’s ability to transform research and formulation expertise into market-ready nutraceutical products. They also show the company’s strength in developing solutions across different health categories, from eye health to metabolic support.